Lumos Pharma, Inc. (LUMO)
Dec 12, 2024 - LUMO was delisted (reason: acquired by Double Point Ventures)
4.340
0.00 (0.00%)
Inactive · Last trade price
on Dec 11, 2024
Lumos Pharma Employees
Lumos Pharma had 33 employees as of December 31, 2023. The number of employees increased by 1 or 3.13% compared to the previous year.
Employees
33
Change (1Y)
1
Growth (1Y)
3.13%
Revenue / Employee
$66,818
Profits / Employee
-$1,058,061
Market Cap
37.54M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 33 | 1 | 3.13% |
Dec 31, 2022 | 32 | 0 | - |
Dec 31, 2021 | 32 | 3 | 10.34% |
Dec 31, 2020 | 29 | 8 | 38.10% |
Dec 31, 2019 | 21 | - | - |
LUMO News
- 12 days ago - Lumos Pharma and Double Point Ventures Announce Successful Completion of Tender Offer and Double Point Ventures' Acquisition of Lumos Pharma - GlobeNewsWire
- 2 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Lumos Pharma, Inc. - PRNewsWire
- 2 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MMLP and LUMO on Behalf of Shareholders - PRNewsWire
- 3 months ago - Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024 - GlobeNewsWire
- 4 months ago - Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 5 months ago - Lumos Pharma, Inc. (LUMO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update - GlobeNewsWire
- 5 months ago - Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - GlobeNewsWire